• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926220400
Device Problem Bent (1059)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/04/2018
Event Type  malfunction  
Manufacturer Narrative
Age at time of event: 18 years or older.Device is a combination product.(b)(4).Device evaluated by mfr: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that stent damage occurred.The target lesion was located in the moderately tortuous right coronary artery.A 4.00 x 20mm synergy¿ drug-eluting stent was advance to treat the lesion.However, the device failed to cross and it was noted that the stent struts were lifted.The procedure was completed with another of the same device.No patient complications nor injuries were reported.
 
Manufacturer Narrative
Device avail.For eval, returned to mfr.On, device returned to mfr., device evaluated by mfr., eval summary, method codes, result codes and conclusion codes updated.Device evaluated by mfr: a synergy ous mr 4.00 x 20mm stent delivery system was returned for analysis.The stent was damaged and moved in a proximal direction exposing the distal balloon wall for a length of 5mm.The manufacturing crimp data for this device was reviewed and there were no anomalies noted.The maximum stent profile was measured and is within the specification.The balloon had not been subjected to any significant positive pressure.There were crimp markings evident on the exposed balloon wall.A visual and tactile examination of the hypotube revealed no issues.An examination of the shaft polymer extrusion found no issues.There were no signs of damage or strain to the port bond.The tip was visually examined and damage was noted.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is operational context as the product meets the design and manufacture specification but due to anatomical/procedural factors encountered during the procedure, performance was limited.(b)(4).
 
Event Description
It was reported that stent damage occurred.The target lesion was located in the moderately tortuous right coronary artery.A 4.00 x 20mm synergy¿ drug-eluting stent was advance to treat the lesion.However, the device failed to cross and it was noted that the stent struts were lifted.The procedure was completed with another of the same device.No patient complications nor injuries were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7614334
MDR Text Key111548537
Report Number2134265-2018-05668
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 06/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/02/2019
Device Model NumberH7493926220400
Device Catalogue Number39262-2040
Device Lot Number0020877898
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/04/2018
Initial Date Manufacturer Received 06/06/2018
Initial Date FDA Received06/19/2018
Supplement Dates Manufacturer Received07/24/2018
Supplement Dates FDA Received08/09/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-